ZimVie Inc ZIMV.OQ reported quarterly adjusted earnings of 26 cents per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of 13 cents. The mean expectation of three analysts for the quarter was for earnings of 21 cents per share. Wall Street expected results to range from 20 cents to 22 cents per share.
Revenue fell 0.1% to $116.66 million from a year ago; analysts expected $112.85 million.
ZimVie Inc's reported EPS for the quarter was a loss of 14 cents.
The company reported a quarterly loss of $3.95 million.
ZimVie Inc shares had risen by 101.2% this quarter and gained 34.8% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 11.1% in the last three months.
In the last 30 days, one analyst negatively revised an earnings estimate
RECOMMENDATIONS
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy."
Wall Street's median 12-month price target for ZimVie Inc is $16.00, about 17.6% below its last closing price of $18.81
This summary was machine generated from LSEG data July 30 at 09:01 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2025 | 0.21 | 0.26 | Beat |
Mar. 31 2025 | 0.21 | 0.27 | Beat |
Dec. 31 2024 | 0.26 | 0.27 | Beat |
Sep. 30 2024 | 0.07 | 0.12 | Beat |